Prognostic factors for nonrelapse mortality in newly diagnosed patients with cGVHD by multivariate proportional hazards analysis
| Prognostic factor . | n (%) . | Coefficient . | HR . | 95% CI . | P value . |
|---|---|---|---|---|---|
| No skin involvement or ≤ 50% | 84 (55.6) | — | 1.00 | — | |
| Skin involvement > 50% | 67 (44.4) | 1.942 | 6.98 | 3.63-13.38 | .0001 |
| Platelet count ≥ 100 K/mm3 | 80 (53.0) | — | 1.00 | — | |
| Platelet count < 100 K/mm3 | 71 (47.0) | 1.291 | 3.64 | 1.95-6.80 | .0001 |
| De novo or quiescent type | 98 (64.9) | — | 1.00 | — | |
| Progressive-type onset | 53 (35.1) | 0.523 | 1.69 | 0.94-3.04 | .08 |
| Prognostic factor . | n (%) . | Coefficient . | HR . | 95% CI . | P value . |
|---|---|---|---|---|---|
| No skin involvement or ≤ 50% | 84 (55.6) | — | 1.00 | — | |
| Skin involvement > 50% | 67 (44.4) | 1.942 | 6.98 | 3.63-13.38 | .0001 |
| Platelet count ≥ 100 K/mm3 | 80 (53.0) | — | 1.00 | — | |
| Platelet count < 100 K/mm3 | 71 (47.0) | 1.291 | 3.64 | 1.95-6.80 | .0001 |
| De novo or quiescent type | 98 (64.9) | — | 1.00 | — | |
| Progressive-type onset | 53 (35.1) | 0.523 | 1.69 | 0.94-3.04 | .08 |
cGVHD indicates chronic graft-versus-host disease; HR, hazard ratio; CI, confidence interval.